Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial - Concepedia

Concepedia

Publication | Open Access

Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial

DOI Full Paper Access

442

Citations

26

References

2012

Year

David C. Smith, Matthew R. Smith, Christopher J. Sweeney, Aymen Elfiky, Christopher J. Logothetis, Paul G. Corn, Nicholas J. Vogelzang, Eric J. Small, Andrea Harzstark, Michael S. Gordon,

Journal of Clinical Oncology

Abstract

Cabozantinib has clinical activity in men with CRPC, including reduction of soft tissue lesions, improvement in PFS, resolution of bone scans, and reductions in bone turnover markers, pain, and narcotic use.

References

	Year	Citations

Page 1